中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2015年
15期
77-78,81
,共3页
帕罗西汀%脑卒中%抑郁%治疗
帕囉西汀%腦卒中%抑鬱%治療
파라서정%뇌졸중%억욱%치료
Paroxetine%Stroke%Depression%Treatment
目的:探讨帕罗西汀对脑卒中后抑郁患者抑郁状态及神经功能恢复的影响。方法选择2012年5月~2014年5月在本院就诊的脑卒中抑郁患者90例,将其随机分为对照组、治疗组,每组45例。对照组给予多虑平治疗,治疗组给予帕罗西汀治疗。比较两组治疗前后神经功能缺损评分的降低幅度、治疗效果、心理状态恢复正常时间、临床治疗总时间、药物不良反应发生率等。结果治疗组患者治疗前后神经功能缺损评分的降低幅度明显大于对照组(P<0.05);治疗效果明显优于对照组(P<0.05);治疗组患者的心理状态恢复正常时间、临床治疗总时间均较对照组显著缩短(P<0.05),药物不良反应发生率较对照组低(P<0.05)。结论帕罗西汀治疗脑卒中后抑郁的临床效果非常明显。
目的:探討帕囉西汀對腦卒中後抑鬱患者抑鬱狀態及神經功能恢複的影響。方法選擇2012年5月~2014年5月在本院就診的腦卒中抑鬱患者90例,將其隨機分為對照組、治療組,每組45例。對照組給予多慮平治療,治療組給予帕囉西汀治療。比較兩組治療前後神經功能缺損評分的降低幅度、治療效果、心理狀態恢複正常時間、臨床治療總時間、藥物不良反應髮生率等。結果治療組患者治療前後神經功能缺損評分的降低幅度明顯大于對照組(P<0.05);治療效果明顯優于對照組(P<0.05);治療組患者的心理狀態恢複正常時間、臨床治療總時間均較對照組顯著縮短(P<0.05),藥物不良反應髮生率較對照組低(P<0.05)。結論帕囉西汀治療腦卒中後抑鬱的臨床效果非常明顯。
목적:탐토파라서정대뇌졸중후억욱환자억욱상태급신경공능회복적영향。방법선택2012년5월~2014년5월재본원취진적뇌졸중억욱환자90례,장기수궤분위대조조、치료조,매조45례。대조조급여다필평치료,치료조급여파라서정치료。비교량조치료전후신경공능결손평분적강저폭도、치료효과、심리상태회복정상시간、림상치료총시간、약물불량반응발생솔등。결과치료조환자치료전후신경공능결손평분적강저폭도명현대우대조조(P<0.05);치료효과명현우우대조조(P<0.05);치료조환자적심리상태회복정상시간、림상치료총시간균교대조조현저축단(P<0.05),약물불량반응발생솔교대조조저(P<0.05)。결론파라서정치료뇌졸중후억욱적림상효과비상명현。
Objective To study the impact of paroxetine on depression state and neurologic function recovery in pa-tients with post-stroke depression. Methods 90 patients with post-stroke depression treated in our hospital from May 2012 to May 2014 were selected,and they were randomly divided into control group and treatment group,and there were 45 patients in each group.The control group was treated with doxepin while treatment group was treated with paroxetine. Reducing degree of the score of neurologic function impairment,the curative effect,the recovery time of psychological status,total time of clinical treatment and the incidence rate of adverse reaction of drug between two groups was com-pared respectively. Results The reducing degree of the score of neurologic function impairment in treatment group be-fore and after medication was significantly higher than that in control group (P<0.05);the curative effect of treatment group was significantly better than that in control group (P<0.05);recovery time of psychological status and total time of clinical treatment in treatment group were both significantly shorter than those in control group (P<0.05);the incidence rate of adverse reaction was lower than that in control group (P<0.05). Conclusion Paroxetine has a significantly clini-cal effect treating post-stroke depression.